Cladis Investment Advisory’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $217K | Hold |
10,000
| – | – | 0.14% | 129 |
|
|
2025
Q1 | $243K | Hold |
10,000
| – | – | 0.18% | 111 |
|
|
2024
Q4 | $209K | Hold |
10,000
| – | – | 0.15% | 121 |
|
|
2024
Q3 | $199K | Hold |
10,000
| – | – | 0.14% | 128 |
|
|
2024
Q2 | $155K | Buy |
+10,000
| New | +$155K | 0.11% | 130 |
|
|
2024
Q1 | – | Sell |
-10,000
| Closed | -$168K | – | 142 |
|
|
2023
Q4 | $168K | Hold |
10,000
| – | – | 0.13% | 134 |
|
|
2023
Q3 | $117K | Hold |
10,000
| – | – | 0.1% | 124 |
|
|
2023
Q2 | $134K | Hold |
10,000
| – | – | 0.12% | 129 |
|
|
2023
Q1 | $166K | Hold |
10,000
| – | – | 0.15% | 131 |
|
|
2022
Q4 | $186K | Hold |
10,000
| – | – | 0.19% | 124 |
|
|
2022
Q3 | $128K | Hold |
10,000
| – | – | 0.14% | 120 |
|
|
2022
Q2 | $70.1K | Hold |
10,000
| – | – | 0.07% | 129 |
|
|
2022
Q1 | $82.9K | Hold |
10,000
| – | – | 0.07% | 146 |
|
|
2021
Q4 | $67.7K | Buy |
+10,000
| New | +$67.7K | 0.05% | 144 |
|